Scholarlink

<p>Vascular dementia (VaD) is the second most common type of dementia lacking effective treatments. Inulin-type hexasaccharide (IHS)&#xa0;extracted from traditional&#xa0;Chinese herbal medicine&#xa0;<i>BaJiTian</i> (<i>Morinda officinalis</i>)&#xa0;has antidepressant effects in many animal models. In this study, we aimed to investigate the therapeutic effects and potential mechanisms of IHS in VaD. Our results showed that IHS could effectively improve cognitive impairment in VaD mice, alleviate histological changes, and promote cerebral blood flow recovery. In addition, we observed that IHS could reduce neuroinflammation and apoptosis in VaD mice. The comprehensive characterization analysis of the serum, fecal, and brain tissue metabolites revealed that IHS regulates multiple metabolic pathways including sphingolipid metabolism, glycerophospholipid metabolism, and&#xa0;pyruvate metabolism in VaD mice. Furthermore,&#xa0;integrative analysis of metabolomics and brain proteomics found that&#xa0;IHS modulates the sphingolipid metabolism pathway to decrease accumulation of ceramide in the brains of VaD mice. Based&#xa0;on the role of ceramide in&#xa0;VaD development and cognitive impairment, IHS improves the pathology of&#xa0;VaD mice at least partially through&#xa0;the sphingolipid metabolism pathway. These results provide a framework for better understanding the mechanisms&#xa0;of the therapeutic effects of IHS in VaD.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Inulin-Type Hexasaccharide Improves Vascular Dementia by Modulating Sphingomyelin Lipid Metabolism

  • 期刊论文

  • 发表日期：

    2026年2月1日

查看全文
  • Jiayao Liu,
  • Jinghuan Wang,
  • Jialin Zhao,
  • Yunzhi Wang,
  • Huibin Wang,
  • Yuyu Zhang,
  • Yinglie Xu,
  • Chunxiang Fan,
  • Xinhua Liu,
  • Jun Chang

摘要

Vascular dementia (VaD) is the second most common type of dementia lacking effective treatments. Inulin-type hexasaccharide (IHS) extracted from traditional Chinese herbal medicine BaJiTian (Morinda officinalis) has antidepressant effects in many animal models. In this study, we aimed to investigate the therapeutic effects and potential mechanisms of IHS in VaD. Our results showed that IHS could effectively improve cognitive impairment in VaD mice, alleviate histological changes, and promote cerebral blood flow recovery. In addition, we observed that IHS could reduce neuroinflammation and apoptosis in VaD mice. The comprehensive characterization analysis of the serum, fecal, and brain tissue metabolites revealed that IHS regulates multiple metabolic pathways including sphingolipid metabolism, glycerophospholipid metabolism, and pyruvate metabolism in VaD mice. Furthermore, integrative analysis of metabolomics and brain proteomics found that IHS modulates the sphingolipid metabolism pathway to decrease accumulation of ceramide in the brains of VaD mice. Based on the role of ceramide in VaD development and cognitive impairment, IHS improves the pathology of VaD mice at least partially through the sphingolipid metabolism pathway. These results provide a framework for better understanding the mechanisms of the therapeutic effects of IHS in VaD.